Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R
- 1 November 2008
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 95 (3) , 174-181
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 37 references indexed in Scilit:
- Translational read‐through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes diseaseAnnals of Neurology, 2009
- Neonatal Diagnosis and Treatment of Menkes DiseaseNew England Journal of Medicine, 2008
- Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosisBlood, 2007
- Internal jugular phlebectasia in Menkes diseaseInternational Journal of Pediatric Otorhinolaryngology, 2007
- Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndromeJournal of Medical Genetics, 2007
- Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicityProceedings of the National Academy of Sciences, 2006
- NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal NeuronsJournal of Neuroscience, 2005
- Study of the neurotransmitter dopamine and the neurotoxin 6‐hydroxydopamine by electrospray ionization coupled with tandem mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Functional Expression of the Menkes Disease Protein Reveals Common Biochemical Mechanisms Among the Copper-transporting P-type ATPasesJournal of Biological Chemistry, 1998
- Early copper-histidine treatment for Menkes diseaseNature Genetics, 1996